ArticleFrontiers in pediatrics2026
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Viral co-infections are common in pediatric Methods: In this retrospective study, we collected data from the medical records of 504 children hospitalized with MPP between July 2021 and December 2024. The information extracted included clinical manifestations, laboratory findings, treatment modalities, and the presence of viral co-infections. Results: Viral co-detection occurred in 193 (38.3%) children, peaking in the 2-4 years age group (47.1%). Among children under 2 years, co-detection was associated with a higher severe disease rate (29.7% vs. 9.5%; Conclusion: Viral co-detection in preschool children with MPP is associated with more severe clinical outcomes, particularly in those under two years of age. Our findings identify pathogen-specific immune response patterns (driven by HMPV and RSV) and elevated serum IL-10 as key risk markers. These findings are hypothesis-generating; the observed associations do not establish causality, and require validation in prospective studies before informing clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.